The aetiology of the hydrocephalus in this case must remain speculative. It is possible that the illness exacerbated an already existing but compensated degree of communicating hydrocephalus. The previous head circumference measurements did not show a large head size but no previous imaging had been done and we cannot know in retrospect. Hypernatraemia may cause haemodynamic alterations leading to renal vein thrombosis2, dilatation and rupture of cerebral vessels and cerebral sinus thrombosis3. Any condition leading to a substantially raised haematocrit predisposes to thrombosis. This may occur, for example, in cyanotic congenital heart disease; or in this case, from a combination of hypernatraemia, dehydration and a high blood glucose. There may have been a preexisting thrombotic state such as protein S or protein C deficiency, or primary antiphospholipid syndrome, but there was no family history of either thrombosis or haemorrhage. Infections can increase the likelihood of venous thrombosis by transiently increasing prothrombotic agents such as anticardiolipin antibodies. Proteins S, C and anticardiolipin antibodies were not checked in this child. It is theoretically possible that cerebral sinus thrombosis can lead on to acute onset hydrocephalus, by the mechanism of reduced cerebrospinal fluid absorption via the arachnoid granulations4. However, the commonly described associa-tion of cerebral sinus thrombosis is benign intracranial hypertension5.
In an infant with an open fontanelle, the diagnosis of raised intracranial pressure as a complication of hypernatraemic hyperosmolar dehydration is straightforward. In older children, neurological deterioration in this condition may be falsely ascribed to metabolic derangement. In the situation of metabolic improvement with neurological deterioration, the possibility of raised intracranial pressure secondary to hydrocephalus or benign intracranial hypertension should be investigated by cranial CT or magnetic resonance imaging. Fibrolipoma of the median nerve is a rare condition presenting most frequently in childhood1. Although benign, the tumour generally progresses, leading to inexorable loss of median nerve function. We report a case that presents a management dilemma.
CASE HISTORY
A 15-year-old girl was seen in late 1998 with a recurrent mass in the first web space of her non-dominant left hand.
She reported neither pain nor median nerve symptoms and the mass had no adverse effects on her playing of the flute and piano. A large, non-tender, non-compressible swelling, centred between the index and thumb metacarpal bones, was palpable both dorsally and in the volar aspect of the palm (Figure 1 ). There was no objective sensory median nerve deficit by moving two-point discrimination and the power and range of movement was full.
In 1994 the patient had been treated at another institution for a symptomless mass in the same location, which had enlarged gradually over the preceding [3] [4] years. This had been excised and the histopathological features were said to be typical of lipoma in addition to some enclosed skeletal muscle fibres. Magnetic resonance imaging (MRI) of the recurrence demonstrated a marked fibrofatty infiltration of the median nerve extending from the wrist joint into the digital branches and characteristic of fibrolipoma ( Figure 2 ). COMMENT Fibrolipoma of the median nerve has been known by various synonyms including fibrofatty overgrowth, fatty infiltration of the nerve, fibrofatty proliferation, intraneural lipoma and lipomatous hamartoma2. It is seldom bilateral, with no known genetic transmission, believed to be congenital in origin and generally presents in childhood2 with the earliest demonstrating the extent of the left median nerve fibrolipoma on coronal view (upper). The axial view, just distal to the carpal tunnel, highlights the 'cable sign' of low intensity neural elements intermixed with high intensity adipose tissue elements recorded cases present at birth3. A variable association with macrodactyly has been reported4. Macroscopically the tumour is soft, fusiform, well demarcated and encapsulated within an intact epineurium. Microscopically there is fibrofatty infiltration of the interfascicular tissue producing dissociation but no fascicular invasion. Additionally, there may be prominent epineurial and perineurial proliferation. The natural history of the disease is gradual progression with compressive symptoms (pain, dysaesthesia, carpal tunnel syndrome) occurring after several years although some patients seem to remain symptom-free for 45-50 years5. Preoperative diagnosis is made by MRI where the tumour presents the characteristic features known as the 'cable sign'6. This is seen best on axial Ti -weighted images where multiple low-signal serpiginous, tubular nerve bundles are juxtaposed with the high-signal hamartomatous component (Figure 2) .
Several treatment options have been proposed, but the emphasis is conservative. If median nerve compression is present, the nerve can be decompressed by division of the transverse carpal ligament; and before the era of MRI diagnosis this was often combined with biopsy of a palmar cutaneous branch2. Interfascicular microdissection has been attempted, but in most cases the results have been disappointing with partial or complete loss of median nerve function7. A further option is radical en bloc excision of the tumour-bearing nerve segment with sural nerve graft interposition. Results, however, have been poor even in children, with their greater potential for neural regeneration than adults. Lack of motor recovery can be treated by opponensplasty2, but there is no satisfactory solution for poor sensory recovery.
Radical surgery, with at least temporary complete loss of median nerve function and a poor outlook for ultimate recovery, cannot be justified in a young patient with normal function. Although some reports suggest that eventual complete loss of median nerve function is inevitable, others do not, or at least suggest that deterioration may be very slow indeed. In this instance we therefore advocate conservative management with clinical and electrophysiological monitoring of nerve function and decompression if and when symptoms or signs indicate.
